We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPortmeirion Regulatory News (PMP)

Share Price Information for Portmeirion (PMP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 257.00
Bid: 250.00
Ask: 264.00
Change: 0.00 (0.00%)
Spread: 14.00 (5.60%)
Open: 257.00
High: 257.00
Low: 257.00
Prev. Close: 255.00
PMP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition in Portmeirion Canada

13 Aug 2020 07:00

RNS Number : 9802V
Portmeirion Group PLC
13 August 2020
 

13 August 2020

 

 

 

 

Portmeirion Group PLC

(the "Group")

 

Acquisition of remaining 50% equity in Portmeirion Canada

 

 

Portmeirion Group PLC, the designer, manufacturer and worldwide distributor of high quality homewares under the Portmeirion, Spode, Royal Worcester, Pimpernel, Wax Lyrical and Nambé brands, is pleased to announce that is has acquired the remaining 50% of the issued share capital of Portmeirion Canada Inc. ("Portmeirion Canada") from Royal Selangor Inc. ("Royal Selangor"). This purchase means the Group now owns 100% of the issued share capital of Portmeirion Canada.

 

As part of the acquisition, key licence distribution agreements in the Canadian marketplace are expected to continue. The Group has also agreed to purchase certain assets from Royal Selangor.

 

The total cash consideration payable by the Group is CA$1.0 million (£0.6 million) which is to be funded from the Group's existing cash resources.

 

For the 12 months to 30 June 2020, Portmeirion Canada recorded sales of CA$3.5 million (unaudited) and contributed approximately CA$0.3 million of net profit to the Group results. As at 30 June 2020, Portmeirion Canada reported unaudited net assets of CA$2.3 million.

 

Portmeirion Canada will continue to operate from its current office and warehouse facilities and retain the combined workforce.

 

Mike Raybould, Chief Executive commented:

 

"We have successfully operated an associated company for our distribution operation in Canada for a number of years. By acquiring the remaining 50% share of Portmeirion Canada and certain trade and assets of Royal Selangor, we obtain control over the selling and distribution process in this market and the rights to key licence distribution agreements. As we previously announced, one of the uses of the recent equity raise proceeds was to build a more significant presence in the Canadian market and it is therefore pleasing to have achieved this strategic goal in such a short timeframe. We see this acquisition as a strong opportunity to revitalise and grow this important market, particularly through further penetration of online channels."

 

Notes: This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.

 

ENQUIRIES:

 

Portmeirion Group PLC:

Mike Raybould

Chief Executive

+44 (0) 1782 743 443

mraybould@portmeiriongroup.com

David Sproston

Group Finance Director

+44 (0) 1782 743 443

dsproston@portmeiriongroup.com

Hudson Sandler:

Dan de Belder

Nick Moore

+44 (0) 207 796 4133

ddebelder@hudsonsandler.com

nmoore@hudsonsandler.com

Panmure Gordon:

(Nominated Adviser and Broker)

+44 (0) 207 886 2500

Freddy Crossley / Joanna Langley

Corporate Finance

James Stearns

Corporate Broking

 

N+1 Singer:

(Joint broker)

+44 (0) 207 496 3000

Peter Steel / Ben Farrow

Corporate Finance

Rachel Hayes

Corporate Broking

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQPTMPTMTMBBFM
Date   Source Headline
17th Apr 20247:00 amRNSAnnual Report & Accounts and Notice of AGM
4th Apr 20242:41 pmRNSHolding(s) in Company
27th Mar 20247:00 amRNSNotice of Investor Presentation
17th Jan 20247:00 amRNSFY23 Trading Update
28th Nov 20235:10 pmRNSHolding(s) in Company
22nd Nov 202311:03 amRNSHolding(s) in Company
19th Oct 20237:00 amRNSUS market product and marketing initiatives
28th Sep 202312:39 pmRNSHolding(s) in Company
18th Sep 202312:02 pmRNSHolding(s) in Company
14th Sep 20237:00 amRNSInterim Results
11th Sep 20237:00 amRNSNotice of Investor Presentation
8th Sep 20237:00 amRNSNotice of Interim Results
20th Jul 20237:00 amRNSTrading Update
12th Jun 20233:37 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSBoard Appointment
23rd May 20231:58 pmRNSAGM Resolutions
23rd May 20237:00 amRNSAGM Trading Statement
16th May 20237:00 amRNSNew Sustainability Strategy and Roadmap
3rd May 202311:39 amRNSGrant of Options
14th Apr 20237:00 amRNSAnnual Report & Accounts and Notice of AGM
23rd Mar 20237:00 amRNSPreliminary Results
6th Mar 20237:00 amRNSNotice of Investor Presentation
27th Feb 20234:43 pmRNSHolding(s) in Company
24th Feb 20237:00 amRNSAppointment of Nomad and Joint Broker
23rd Feb 20237:00 amRNSAIM Rule 17 Schedule 2(g) Update
12th Jan 20237:00 amRNSTrading Update
3rd Nov 20227:00 amRNSAnnouncement of new design collaboration
13th Oct 20223:50 pmRNSHolding(s) in Company
26th Sep 20227:00 amRNSExercise of Options and PDMR Shareholdings
15th Sep 20227:00 amRNSInterim Results
8th Sep 20227:00 amRNSLaunch of new UK ecommerce sites
7th Sep 20227:00 amRNSInvestor Results Presentation
2nd Sep 20223:08 pmRNSNotice of Interim Results
15th Aug 20227:00 amRNSAcquisition of AromaWorks London
14th Jul 20227:00 amRNSTrading Update
7th Jul 20227:00 amRNSDirectorate Changes
1st Jul 202210:59 amRNSHolding(s) in Company
29th Jun 20223:18 pmRNSHolding(s) in Company
15th Jun 20223:08 pmRNSDirectors’ Dealings
19th May 20222:38 pmRNSAGM Resolutions
19th May 20227:00 amRNSAGM Trading Statement
12th May 202212:54 pmRNSHolding(s) in Company
26th Apr 20221:49 pmRNSGrant of Options
17th Mar 20227:00 amRNSPreliminary Results
7th Mar 20227:00 amRNSInvestor Results Presentation
24th Feb 20224:20 pmRNSAIM Rule 17 Schedule 2(g) Update
2nd Feb 202211:00 amRNSCapital Markets Day
12th Jan 20227:00 amRNSTrading Update
11th Nov 20217:15 amRNSTrading Update
14th Sep 20217:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.